Mark P. Lappe
Founder, Chief Executive Officer
The Inhibrx Team
Mark P. Lappe
Founder, Chief Executive Officer
Brendan P. Eckelman, Ph.D.
Founder, Chief Scientific Officer, EVP Corporate Strategy
Quinn Deveraux, Ph.D.
Founder, EVP Early Research
Klaus W. Wagner, M.D., Ph.D.
EVP Chief Medical Officer
Kelly Deck, C.P.A.
Chief Financial Officer
Ashraf Amanullah, Ph.D.
EVP, Chief Technical Operations Officer
Analeah Heidt, Ph.D.
EVP Translational Research
Jeffrey Jensen
EVP Clinical Operations
John Timmer, Ph.D.
VP Protein Engineering
Leah Pollema, J.D.
VP, General Counsel
The Inhibrx Board
Mark P. Lappe
Chairman
Brendan P. Eckelman, Ph.D.
Director
Douglas G. Forsyth
Director
Jon Faiz Kayyem, Ph.D.
Director
Kimberly Manhard
Director
